We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$2.11B
AUM Growth
+$194M
Cap. Flow
+$818M
Cap. Flow %
38.75%
Top 10 Hldgs %
58.11%
Holding
879
New
298
Increased
119
Reduced
90
Closed
306

Top Buys

Rank Stock Value
1
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$47M
2
FTAI icon
FTAI Aviation
FTAI
+$42.9M
3
CLDX icon
Celldex Therapeutics
CLDX
+$29.1M
4
ESTA icon
Establishment Labs
ESTA
+$17.5M
5
VMW
VMware, Inc
VMW
+$15.1M

Top Sells

Rank Stock Value
1
WPF
Foley Trasimene Acquisition Corp.
WPF
+$15.1M
2
BPYU
Brookfield Property REIT Inc. Class A Common Stock
BPYU
+$14.4M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.6M
4
SST icon
System1
SST
+$9.9M
5
NICE icon
Nice
NICE
+$7.38M

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Consumer Discretionary 11.05%
3 Financials 5.53%
4 Technology 3.61%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRA
376
CALL
DELISTED
Kraton Corporation
KRA
$56K ﹤0.01%
+22,200
New +$882K
LGV.WS
377
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$55K ﹤0.01%
+42,827
New +$57.7K
BKSY icon
378
PUT
BlackSky Technology
BKSY
$1.22B
$54K ﹤0.01%
+2,250
New +$185K
GACQW
379
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
$54K ﹤0.01%
+115,109
New +$58.1K
IONS icon
380
PUT
Ionis Pharmaceuticals
IONS
$9.21B
$53K ﹤0.01%
20,000
-31,600
-61% -$1.19M
MVLAW
381
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$53K ﹤0.01%
+56,175
New +$55.9K
FRXB.WS
382
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$53K ﹤0.01%
61,369
+1,010
+2% +$1.11K
CND.WS
383
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$53K ﹤0.01%
30,000
-120,000
-80% -$223K
CRXT
384
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$53K ﹤0.01%
+10,000
New +$89.9K
PIIIW icon
385
P3 Health Partners Inc Warrant
PIIIW
$191K
$51K ﹤0.01%
57,399
-109,267
-66% -$131K
MAQCW
386
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$51K ﹤0.01%
+92,109
New +$50.6K
DRNA
387
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$51K ﹤0.01%
+2,514
New +$69.4K
UTHR icon
388
CALL
United Therapeutics
UTHR
$22.1B
$49K ﹤0.01%
+10,000
New +$1.97M
SBII.WS
389
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$49K ﹤0.01%
+61,700
New +$59K
ALNY icon
390
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$48K ﹤0.01%
15,000
-400
-3% -$75K
BNZIW
391
DELISTED
Banzai International Warrant
BNZIW
$48K ﹤0.01%
81,899
– –
TBCH
392
CALL
Turtle Beach Corp
TBCH
$256M
$48K ﹤0.01%
+101,700
New +$2.97M
FVIV.WS
393
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$46K ﹤0.01%
57,096
+21,422
+60% +$23.4K
LICY.WS
394
DELISTED
Li-Cycle Holdings Corp. Redeemable Warrants, each whole warrant exercisable for one Common Share at
LICY.WS
$46K ﹤0.01%
+19,000
New +$34.9K
ACRO.WS
395
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$46K ﹤0.01%
+50,000
New +$43K
ZTAQW
396
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$45K ﹤0.01%
+49,873
New +$57.2K
AMRN
397
Amarin Corp
AMRN
$296M
$44K ﹤0.01%
+432
New +$42.4K
DCPH
398
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$44K ﹤0.01%
+1,292
New +$41.2K
LMACW
399
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$43K ﹤0.01%
29,506
-20,494
-41% -$36.9K
QQQ icon
400
CALL
Invesco QQQ Trust
QQQ
$478B
$42K ﹤0.01%
5,000
-2,500
-33% -$921K
14 15
16
17 18

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2021 Portfolio in Review

As of Q3 2021, Cowen and Company held 879 positions worth $2.11B, up 10% from $1.92B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Cowen and Company deployed $818M of net new capital in Q3 2021, opening 298 new positions and adding to 119 existing holdings. Its largest new stake was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Nice, an estimated $7.38M trimmed.

  • Cowen and Company's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.
  • Cowen and Company added most to FTAI Aviation in Q3 2021, an estimated $42.9M increase.
  • Cowen and Company's biggest Q3 2021 reduction was Nice, cutting an estimated $7.38M.
  • Cowen and Company fully exited Foley Trasimene Acquisition Corp. in Q3 2021, selling an estimated $15.1M.
  • Cowen and Company's ten largest holdings make up 58% of its $2.11B portfolio in Q3 2021.
  • Cowen and Company opened 298 new positions and closed 306 in Q3 2021.
  • Cowen and Company's portfolio value rose 10% quarter-over-quarter to $2.11B.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.